Atlas Trials

A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency

Clinical trial NCT05531279 · UNKNOWN

Trial details

NCT number
NCT05531279
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Severe Aplastic Anemia
Start date
2022-06-05
Primary completion
2025-06-05
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.